Fluoroquinolone Pharmacodynamics
Open Access
- 15 December 2001
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 33 (12) , 2091-2092
- https://doi.org/10.1086/323748
Abstract
Sir—We read with interest the paper by Schentag et al. [1], which presented the authors' perspectives on the fluoroquinolones, their pharmacodynamic relationships, and their associations with various outcome end points. A little light might be shed with advantage upon the inconsistencies of the terminology, methods, and conclusions made by the authors.Keywords
This publication has 8 references indexed in Scilit:
- Pharmacodynamics of Fluoroquinolones against Streptococcus pneumoniae in Patients with Community-Acquired Respiratory Tract InfectionsAntimicrobial Agents and Chemotherapy, 2001
- Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae in the United States during 1999–2000, Including a Comparison of Resistance Rates since 1994–1995Antimicrobial Agents and Chemotherapy, 2001
- What Have We Learned from Pharmacokinetic and Pharmacodynamic Theories?Clinical Infectious Diseases, 2001
- Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997–1998Journal of Antimicrobial Chemotherapy, 1999
- Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniaeJournal of Antimicrobial Chemotherapy, 1999
- Pharmacodynamics of LevofloxacinJAMA, 1998
- Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996–1997 respiratory seasonDiagnostic Microbiology and Infectious Disease, 1997
- General Guidelines for the Clinical Evaluation of Anti-Infective Drug ProductsClinical Infectious Diseases, 1992